Alberto Risueño

1.7k total citations
25 papers, 678 citations indexed

About

Alberto Risueño is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Alberto Risueño has authored 25 papers receiving a total of 678 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 12 papers in Genetics and 11 papers in Molecular Biology. Recurrent topics in Alberto Risueño's work include Acute Myeloid Leukemia Research (12 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers). Alberto Risueño is often cited by papers focused on Acute Myeloid Leukemia Research (12 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers). Alberto Risueño collaborates with scholars based in United States, Germany and Spain. Alberto Risueño's co-authors include Javier De Las Rivas, Celia Fontanillo, Carlos Alberto Vanegas Prieto, Marcel E. Dinger, Jesús María Hernández‐Rivas, Marcos González, Encarnación Fermiñán, Norma C. Gutiérrez, María Eugenia Sarasquete and Irena Misiewicz-Krzemińska and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Bioinformatics.

In The Last Decade

Alberto Risueño

25 papers receiving 670 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alberto Risueño United States 12 437 262 192 91 87 25 678
Valentina Serafin Italy 14 545 1.2× 294 1.1× 96 0.5× 47 0.5× 162 1.9× 28 783
Nicola D. Roberts United Kingdom 7 238 0.5× 195 0.7× 163 0.8× 133 1.5× 86 1.0× 7 554
Haitao Bai China 14 474 1.1× 293 1.1× 173 0.9× 55 0.6× 115 1.3× 46 754
Rizi Ai United States 12 332 0.8× 126 0.5× 85 0.4× 46 0.5× 79 0.9× 17 587
Christopher F. Bassil United States 7 602 1.4× 109 0.4× 196 1.0× 61 0.7× 121 1.4× 11 754
Garrett W. Rhyasen United States 8 288 0.7× 139 0.5× 217 1.1× 65 0.7× 91 1.0× 11 555
Susana Lisboa Portugal 12 241 0.6× 90 0.3× 97 0.5× 84 0.9× 93 1.1× 25 433
Lyndsey Bolanos United States 12 455 1.0× 162 0.6× 374 1.9× 104 1.1× 106 1.2× 24 801
Cristina Mirantes Spain 13 279 0.6× 112 0.4× 93 0.5× 45 0.5× 168 1.9× 17 595
Koichi R. Katsumura United States 18 578 1.3× 87 0.3× 257 1.3× 105 1.2× 107 1.2× 24 863

Countries citing papers authored by Alberto Risueño

Since Specialization
Citations

This map shows the geographic impact of Alberto Risueño's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alberto Risueño with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alberto Risueño more than expected).

Fields of papers citing papers by Alberto Risueño

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alberto Risueño. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alberto Risueño. The network helps show where Alberto Risueño may publish in the future.

Co-authorship network of co-authors of Alberto Risueño

This figure shows the co-authorship network connecting the top 25 collaborators of Alberto Risueño. A scholar is included among the top collaborators of Alberto Risueño based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alberto Risueño. Alberto Risueño is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Menezes, Daniel L., Andrew H. Wei, Hartmut Döhner, et al.. (2023). P411: LONGITUDINAL CHARACTERIZATION OF MOLECULAR VARIANTS AT REMISSION AND RELAPSE: SUBANALYSIS OF THE QUAZAR AML-001 TRIAL. HemaSphere. 7(S3). e930876b–e930876b. 1 indexed citations
2.
Risueño, Alberto, Wendy L. See, Thomas Prébet, et al.. (2023). Molecular Features Associated with Response to Enasidenib Plus Azacitidine in Newly Diagnosed IDH2-Mutated Acute Myeloid Leukemia. 4(1). 20–35. 1 indexed citations
3.
Menezes, Daniel L., Wendy L. See, Alberto Risueño, et al.. (2023). Oral azacitidine modulates the bone marrow microenvironment in patients with acute myeloid leukaemia in remission: A subanalysis from the QUAZAR AML‐001 trial. British Journal of Haematology. 201(6). 1129–1143. 3 indexed citations
4.
Garbowski, Maciej, Alberto Risueño, Jeevan K. Shetty, et al.. (2023). Luspatercept stimulates erythropoiesis, increases iron utilization, and redistributes body iron in transfusion‐dependent thalassemia. American Journal of Hematology. 99(2). 182–192. 13 indexed citations
5.
Menezes, Daniel L., Arnaud Amzallag, Wendy L. See, et al.. (2023). Clonal Dynamics of Gene Mutations during Oral Azacitidine Maintenance Therapy in Patients with Acute Myeloid Leukemia (AML): Outcomes from the QUAZAR AML-001 Trial. Blood. 142(Supplement 1). 1582–1582. 1 indexed citations
6.
Roboz, Gail J., Farhad Ravandi, Andrew H. Wei, et al.. (2022). Oral azacitidine prolongs survival of patients with AML in remission independently of measurable residual disease status. Blood. 139(14). 2145–2155. 37 indexed citations
7.
Jeyaraju, Danny V., Sheida Hayati, Ann Polonskaia, et al.. (2022). Fedratinib Induces Cytokine Changes Correlating with Clinical Response in Ruxolitinib Exposed Myelofibrosis Patients: Biomarker Analysis from the Freedom Trial. Blood. 140(Supplement 1). 3865–3867. 1 indexed citations
8.
Döhner, Hartmut, Andrew H. Wei, Gail J. Roboz, et al.. (2022). Prognostic impact of NPM1 and FLT3 mutations in patients with AML in first remission treated with oral azacitidine. Blood. 140(15). 1674–1685. 26 indexed citations
9.
Risueño, Alberto, Patrick R. Hagner, Fadi Towfic, et al.. (2020). Leveraging Gene Expression Subgroups to Classify DLBCL Patients and Enrich for Clinical Benefit to a Novel Agent. Blood. 135(13). 1008–1018. 11 indexed citations
10.
Platzbecker, Uwe, Alberto Risueño, Esther T. Chan, et al.. (2020). Effect of Luspatercept on Biomarkers of Erythropoiesis in Patients (Pts) with Lower-Risk Myelodysplastic Syndromes (LR-MDS) in the Medalist Trial. Blood. 136(Supplement 1). 38–39. 2 indexed citations
11.
12.
Levy, Benjamin, Giuseppe Giaccone, Benjamin Besse, et al.. (2019). Randomised phase 2 study of pembrolizumab plus CC-486 versus pembrolizumab plus placebo in patients with previously treated advanced non-small cell lung cancer. European Journal of Cancer. 108. 120–128. 48 indexed citations
13.
Risueño, Alberto, Beatriz Rosón, Anna Dolnik, et al.. (2014). A robust estimation of exon expression to identify alternative spliced genes applied to human tissues and cancer samples. BMC Genomics. 15(1). 879–879. 11 indexed citations
14.
Hernández‐Sánchez, María, Alexander Kohlmann, Rocí­o Benito, et al.. (2014). TET2Overexpression in Chronic Lymphocytic Leukemia Is Unrelated to the Presence ofTET2Variations. BioMed Research International. 2014. 1–6. 12 indexed citations
15.
Hernández‐Rivas, José‐Ángel, Rocí­o Benito, Norma C. Gutiérrez, et al.. (2012). Molecular Characterization of Chronic Lymphocytic Leukemia Patients with a High Number of Losses in 13q14. PLoS ONE. 7(11). e48485–e48485. 30 indexed citations
16.
Hernández‐Rivas, José‐Ángel, Alberto Risueño, Encarnación Fermiñán, et al.. (2012). Molecular Characterization of Chronic Lymphocytic Leukemia Patients with a High Number of Losses in 13q14.. Blood. 120(21). 2871–2871. 1 indexed citations
17.
Robledo, Cristina, Juan Luis Garcı́a, Marcos González, et al.. (2012). Identification of a novel recurrent gain on 20q13 in chronic lymphocytic leukemia by array CGH and gene expression profiling. Annals of Oncology. 23(8). 2138–2146. 12 indexed citations
18.
Gutiérrez, Norma C., María Eugenia Sarasquete, Irena Misiewicz-Krzemińska, et al.. (2010). Deregulation of microRNA expression in the different genetic subtypes of multiple myeloma and correlation with gene expression profiling. Leukemia. 24(3). 629–637. 169 indexed citations
19.
Risueño, Alberto, Celia Fontanillo, Marcel E. Dinger, & Javier De Las Rivas. (2010). GATExplorer: Genomic and Transcriptomic Explorer; mapping expression probes to gene loci, transcripts, exons and ncRNAs. BMC Bioinformatics. 11(1). 221–221. 71 indexed citations
20.
Prieto, Carlos Alberto Vanegas, Alberto Risueño, Celia Fontanillo, & Javier De Las Rivas. (2008). Human Gene Coexpression Landscape: Confident Network Derived from Tissue Transcriptomic Profiles. PLoS ONE. 3(12). e3911–e3911. 200 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valentina Serafin Breakdown of academic impact, for papers by Nicola D. Roberts Breakdown of academic impact, for papers by Haitao Bai Breakdown of academic impact, for papers by Rizi Ai Breakdown of academic impact, for papers by Christopher F. Bassil Breakdown of academic impact, for papers by Garrett W. Rhyasen Breakdown of academic impact, for papers by Susana Lisboa Breakdown of academic impact, for papers by Lyndsey Bolanos Breakdown of academic impact, for papers by Cristina Mirantes Breakdown of academic impact, for papers by Koichi R. Katsumura
Rankless by CCL
2026